SEC Tracker
Get the app

Carlsmed CARL

Carlsmed reports 65% revenue growth in Q3 2026

Carlsmed (CARL) filed an 8-K with the SEC on Nov 10, 2026, 4:06 pm ET. Source: the filing on SEC EDGAR.

Item 2.02 Reports results

Form
8-K
Filed
Importance
Major
  1. Q3 2026 revenue of $21.6 million, up 65% YoY
  2. Full-year 2026 revenue guidance raised to $78 million to $80 million
  3. Net loss of $12.2 million for Q3 2026, compared to $8.5 million in Q3 2025

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Carlsmed files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.